Literature DB >> 20614263

p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.

Jonathan B McHugh1, Aaron P Hoschar, Mari Dvorakova, Anil V Parwani, E Leon Barnes, Raja R Seethala.   

Abstract

Metastatic renal cell carcinoma (RCC) can pose diagnostic challenges in the head and neck often resembling benign and malignant oncocytic lesions. Immunohistochemical panels have been reported to help with this differential but are not entirely specific or sensitive. We have noticed that p63 routinely stains salivary gland oncocytomas but not metastatic RCC. Nineteen oncocytomas, 9 cases of oncocytosis, 9 oncocytic carcinomas and 16 head and neck metastatic RCC were studied. Morphologic features evaluated were cytoplasmic character (clear versus oncocytic), Fuhrman nuclear grade, mitotic rate, growth pattern, presence of lumens/blood lakes and stromal characteristics. Tumors were stained with antibodies to p63, renal cell carcinoma marker (RCCm), CD10, and vimentin. Eight benign oncocytic tumors (29%) had clear cell features while 6 metastatic RCC (37%) had oncocytic features. Median Fuhrman nuclear grade was 2 in oncocytoma and oncocytosis and 3 both oncocytic carcinoma and metastatic RCC. Mitotic rates were only significantly different between benign oncocytic tumors and metastatic RCC. All oncocytomas had lumina compared to half of metastatic RCC, all of which also demonstrated blood lakes. Seven benign oncocytic tumors (25%) and 5 oncocytic carcinomas (56%) had RCC-like vascular stroma. All primary salivary gland tumors were positive for p63, predominately in basal cell-type distribution. None of the metastatic RCC was positive. RCCm was entirely specific but lacked sensitivity for metastatic RCC while CD10 and vimentin showed variable sensitivity and specificity. While clinical history and morphology usually are adequate, demonstration of p63 staining can definitively exclude metastatic RCC from the differential diagnosis of similar appearing tumors in salivary glands, namely oncocytoma and oncocytic carcinoma, with 100% specificity and sensitivity. While RCCm, CD10, and vimentin performed adequately, they were significantly less reliable than p63 with both false positives and false negatives.

Entities:  

Keywords:  Metastatic renal cell carcinoma; Oncocytic carcinoma; Oncocytoma; p63

Mesh:

Substances:

Year:  2007        PMID: 20614263      PMCID: PMC2807526          DOI: 10.1007/s12105-007-0031-4

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  34 in total

1.  Association of p63 with proliferative potential in normal and neoplastic human keratinocytes.

Authors:  R Parsa; A Yang; F McKeon; H Green
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

Review 2.  Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker.

Authors:  Jorge S Reis-Filho; Fernando C Schmitt
Journal:  Adv Anat Pathol       Date:  2002-09       Impact factor: 3.875

3.  p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.

Authors:  M Barbareschi; L Pecciarini; M G Cangi; E Macrì; A Rizzo; G Viale; C Doglioni
Journal:  Am J Surg Pathol       Date:  2001-08       Impact factor: 6.394

4.  Ultrastructure of oncocytoma of the parotid gland.

Authors:  B Tandler; R V Hutter; R A Erlandson
Journal:  Lab Invest       Date:  1970-12       Impact factor: 5.662

5.  Head and neck metastases from renal carcinomas.

Authors:  R Boles; J Cerny
Journal:  Mich Med       Date:  1971-07

6.  P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues.

Authors:  Hadi Bilal; Adriana Handra-Luca; Jacques-Charles Bertrand; Pierre J Fouret
Journal:  J Histochem Cytochem       Date:  2003-02       Impact factor: 2.479

7.  Expression profiles of p53, p63, and p73 in benign salivary gland tumors.

Authors:  Anette Weber; Larissa Langhanki; Alexander Schütz; Andreas Gerstner; Friedrich Bootz; Christian Wittekind; Andrea Tannapfel
Journal:  Virchows Arch       Date:  2002-09-11       Impact factor: 4.064

8.  P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors.

Authors:  Cord Langner; Manfred Ratschek; Oleksiy Tsybrovskyy; Luigi Schips; Richard Zigeuner
Journal:  J Histochem Cytochem       Date:  2003-08       Impact factor: 2.479

9.  Metastatic renal cell carcinoma to the head and neck.

Authors:  Keith M Pritchyk; Bradley A Schiff; Kenneth A Newkirk; Edward Krowiak; Ziad E Deeb
Journal:  Laryngoscope       Date:  2002-09       Impact factor: 3.325

10.  Oncocytic neoplasms of the parotid gland: a 16-year institutional review.

Authors:  Randolph B Capone; Patrick K Ha; William H Westra; Thomas M Pilkington; James J Sciubba; Wayne M Koch; Charles W Cummings
Journal:  Otolaryngol Head Neck Surg       Date:  2002-06       Impact factor: 3.497

View more
  13 in total

1.  My journey into the world of salivary gland sebaceous neoplasms.

Authors:  Douglas R Gnepp
Journal:  Head Neck Pathol       Date:  2012-03-20

2.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.

Authors:  Raja R Seethala; Göran Stenman
Journal:  Head Neck Pathol       Date:  2017-02-28

Review 3.  Hyalinizing clear cell carcinoma of salivary gland: a review and update.

Authors:  Ilan Weinreb
Journal:  Head Neck Pathol       Date:  2013-07-03

4.  Granular cell tumor of thyroid: a case series with molecular characterization highlighting unique pitfalls.

Authors:  Pooja Srivastava; Arnaud Da Cruz Paula; Britta Weigelt; Fresia Pareja; Jorge S Reis-Filho; Linwah Yip; Liron Pantanowitz; Raja R Seethala
Journal:  Endocrine       Date:  2022-02-17       Impact factor: 3.925

5.  Evaluation of PAX2 and PAX8 expression in salivary gland neoplasms.

Authors:  Randall T Butler; Megan A Alderman; Lester D R Thompson; Jonathan B McHugh
Journal:  Head Neck Pathol       Date:  2014-04-26

6.  Salivary type tumors seen in consultation.

Authors:  Simion I Chiosea; Robert Peel; E Leon Barnes; Raja R Seethala
Journal:  Virchows Arch       Date:  2009-03-07       Impact factor: 4.064

Review 7.  Histopathological findings in parotid gland metastases from renal cell carcinoma.

Authors:  Roderik Mrena; Ilmo Leivo; Fabricio Passador-Santos; Jaana Hagström; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-26       Impact factor: 2.503

8.  Low-grade non-intestinal-type sinonasal adenocarcinoma: a histologically distinctive but molecularly heterogeneous entity.

Authors:  Lisa M Rooper; Lester D R Thompson; Jeffrey Gagan; Jacqueline Siok Gek Hwang; Nyall R London; Michael W Mikula; Todd M Stevens; Justin A Bishop
Journal:  Mod Pathol       Date:  2022-03-23       Impact factor: 8.209

9.  Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice.

Authors:  Toshitaka Nagao; Eiichi Sato; Rie Inoue; Hisashi Oshiro; Reisuke H Takahashi; Takeshi Nagai; Maki Yoshida; Fumie Suzuki; Hiyo Obikane; Mitsumasa Yamashina; Jun Matsubayashi
Journal:  Acta Histochem Cytochem       Date:  2012-09-22       Impact factor: 1.938

10.  A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma.

Authors:  Yueping Zhan; Wenna Guo; Ying Zhang; Qiang Wang; Xin-jian Xu; Liucun Zhu
Journal:  Comput Math Methods Med       Date:  2015-10-11       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.